Sirtuins Hold Promise for Bone Repair and Metabolic Regulation
Researchers at the Department of Cardiothoracic Surgery have published a new report on the role of sirtuins in bone repair, highlighting their potential as therapeutic targets in the metabolic regulation of bone repair. According to the study, impaired clinical fracture healing remains a major challenge, particularly in patients with metabolic disorders or comorbidities such as diabetes and osteoporosis. The researchers found that sirtuins, NAD-dependent deacetylases, exhibit cell-specific expression and regulate critical processes in osteoblasts and osteoclasts, linking glucose metabolism with bone remodeling.
Key Takeaways:
- The study found that sirtuins influence key pathways such as Wnt/b-catenin, AMPK, and mTOR, offering novel insights into the mechanisms of fracture healing.
- Emerging pharmacological strategies targeting sirtuins show promising results in preclinical models, highlighting their potential as therapeutic targets in the metabolic regulation of bone repair.
- The research emphasized the importance of understanding the role of sirtuins in glucose metabolism and bone remodeling, with the goal of developing novel interventions for treating impaired bone repair.
- The study highlights the need for further research into the mechanisms of sirtuins and their potential as therapeutic targets for treating metabolic disorders and bone diseases.
- The researchers propose that sirtuin-based interventions could be used to regulate bone repair and metabolism, offering new avenues for treating bone fractures and related conditions.
- The study emphasizes the potential of sirtuins as therapeutic targets in the treatment of metabolic disorders and bone diseases.
- The research was conducted by investigators at the Department of Cardiothoracic Surgery, Naval Medical Center, Naval Medical University (Second Military Medical University), Shanghai, China.
- The study's findings are published in the International Journal of General Medicine, Volume 18, Issue 1, pp. 5013-5031.
Statistics:
- Impaired clinical fracture healing affects millions of people worldwide, with surgical treatment often insufficient in patients with metabolic disorders or comorbidities.
- Sirtuins have been shown to regulate critical processes in osteoblasts and osteoclasts, linking glucose metabolism with bone remodeling.
- Emerging pharmacological strategies targeting sirtuins have shown promising results in preclinical models, with potential for treating impaired bone repair and related conditions.
- The study highlights the need for further research into the mechanisms of sirtuins and their potential as therapeutic targets, with a focus on developing novel interventions for treating bone fractures and related conditions.
Sources:
- The Role of Sirtuins in Bone Repair From the Perspective of Glucose Metabolism. International Journal of General Medicine, 2025, Volume 18(Issue 1):5013-5031.
- NewsRx. Study Findings on Sirtuins Discussed by Researchers at Department of Cardiothoracic Surgery (The Role of Sirtuins in Bone Repair From the Perspective of Glucose Metabolism). Cardiovascular Week. September 15, 2025; p 2161.